Skip to main content
Erschienen in: Journal of Endocrinological Investigation 11/2017

01.11.2017 | Original Article

Associations of blood glucose dynamics with antihyperglycemic treatment and glycemic variability in type 1 and type 2 diabetes

verfasst von: K.-D. Kohnert, P. Heinke, L. Vogt, P. Augstein, A. Thomas, E. Salzsieder

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims

The dynamical structure of glucose fluctuation has largely been disregarded in the contemporary management of diabetes.

Methods

In a retrospective study of patients with diabetes, we evaluated the relationship between glucose dynamics, antihyperglycemic therapy, glucose variability, and glucose exposure, while taking into account potential determinants of the complexity index. We used multiscale entropy (MSE) analysis of continuous glucose monitoring data from 131 subjects with type 1 (n = 18), type 2 diabetes (n = 102), and 11 nondiabetic control subjects. We compared the MSE complexity index derived from the glucose time series among the treatment groups, after adjusting for sex, age, diabetes duration, body mass index, and carbohydrate intake.

Results

In type 2 diabetic patients who were on a diet or insulin regimen with/without oral agents, the MSE index was significantly lower than in nondiabetic subjects but was lowest in the type 1 diabetes group (p < 0.001). The decline in the MSE complexity across the treatment groups correlated with increasing glucose variability and glucose exposure. Statistically, significant correlations existed between higher MSE complexity indices and better glycemic control. In multivariate regression analysis, the antidiabetic therapy was the most powerful predictor of the MSE (β = −0.940 ± 0.242, R 2 = 0.306, p < 0.001), whereas the potential confounders failed to contribute.

Conclusions

The loss of dynamical complexity in glucose homeostasis correlates more closely with therapy modalities and glucose variability than with clinical measures of glycemia. Thus, targeting the glucoregulatory system by adequate therapeutic interventions may protect against progressive worsening of diabetes control.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kohnert KD, Heinke P, Vogt L, Salzsieder E (2015) Utility of different glycemic control metrics for optimizing management of diabetes. World J Diabetes 6:17–29CrossRefPubMedPubMedCentral Kohnert KD, Heinke P, Vogt L, Salzsieder E (2015) Utility of different glycemic control metrics for optimizing management of diabetes. World J Diabetes 6:17–29CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Sartore G, Chilelli NC, Burlina S et al (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol 49:S153–S160CrossRefPubMed Sartore G, Chilelli NC, Burlina S et al (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol 49:S153–S160CrossRefPubMed
3.
Zurück zum Zitat Bergenstal RM, Ahman AJ, Bailey T et al (2013) Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 15:198–211CrossRefPubMed Bergenstal RM, Ahman AJ, Bailey T et al (2013) Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 15:198–211CrossRefPubMed
5.
Zurück zum Zitat Bremer T, Gough DA (1999) Is blood glucose predictable from previous values? A solicitation for data. Diabetes 48:445–451CrossRefPubMed Bremer T, Gough DA (1999) Is blood glucose predictable from previous values? A solicitation for data. Diabetes 48:445–451CrossRefPubMed
6.
Zurück zum Zitat Kovatchev BP, Clarke WL, Breton M, Brayman K, McCall A (2005) Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther 7:849–862CrossRefPubMed Kovatchev BP, Clarke WL, Breton M, Brayman K, McCall A (2005) Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther 7:849–862CrossRefPubMed
7.
Zurück zum Zitat Crenier L (2014) Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion. Diabetes Technol Ther 16:1–8CrossRef Crenier L (2014) Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion. Diabetes Technol Ther 16:1–8CrossRef
8.
Zurück zum Zitat Khovanova NA, Khovanov IA, Shabno L, Griffiths F, Holt TA (2013) Characterisation of linear predictability and non-stationarity of subcutaneous glucose profiles. Comput Methods Programs Biomed 110:260e7CrossRef Khovanova NA, Khovanov IA, Shabno L, Griffiths F, Holt TA (2013) Characterisation of linear predictability and non-stationarity of subcutaneous glucose profiles. Comput Methods Programs Biomed 110:260e7CrossRef
9.
Zurück zum Zitat Ogata H, Tokuyama K, Nagasaka S et al (2012) The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus. Metabolism 61:1041–1050CrossRefPubMed Ogata H, Tokuyama K, Nagasaka S et al (2012) The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus. Metabolism 61:1041–1050CrossRefPubMed
10.
Zurück zum Zitat Yamamoto N, Kubo Y, Ishizawa K et al (2010) Detrended fluctuation analysis is considered to be useful as a new indicator for short-term glucose complexity. Diabetes Technol Ther 12:775–783CrossRefPubMed Yamamoto N, Kubo Y, Ishizawa K et al (2010) Detrended fluctuation analysis is considered to be useful as a new indicator for short-term glucose complexity. Diabetes Technol Ther 12:775–783CrossRefPubMed
11.
Zurück zum Zitat Thomas F, Signal M, Chase JG (2015) Using continuous glucose monitoring data and detrended fluctuation analysis to determine patient condition: a review. J Diabetes Sci Technol 9:1327–1335CrossRefPubMedPubMedCentral Thomas F, Signal M, Chase JG (2015) Using continuous glucose monitoring data and detrended fluctuation analysis to determine patient condition: a review. J Diabetes Sci Technol 9:1327–1335CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Crenier L, Lytrivi M, Van Dalem A, Keymeulen B, Corvilain B (2016) Glucose complexity estimates insulin resistance in either nondiabetic individuals or in type 1 diabetes. J Clin Endocrinol Metab. doi:10.1210/jc.2015-4035 PubMed Crenier L, Lytrivi M, Van Dalem A, Keymeulen B, Corvilain B (2016) Glucose complexity estimates insulin resistance in either nondiabetic individuals or in type 1 diabetes. J Clin Endocrinol Metab. doi:10.​1210/​jc.​2015-4035 PubMed
13.
Zurück zum Zitat Chen JL, Chen PF, Wang HM (2014) Decreased complexity of glucose dynamics in diabetes: evidence from multiscale entropy analysis of continuous glucose monitoring system data. Am J Physiol Regul Integr Comp Physiol 307:R179–R183CrossRefPubMed Chen JL, Chen PF, Wang HM (2014) Decreased complexity of glucose dynamics in diabetes: evidence from multiscale entropy analysis of continuous glucose monitoring system data. Am J Physiol Regul Integr Comp Physiol 307:R179–R183CrossRefPubMed
14.
Zurück zum Zitat Costa MD, Henriques T, Munshi MN, Segal AR, Goldberger AL (2014) Dynamical glucometry: use of multiscale entropy analysis in diabetes. Chaos 24:033139CrossRefPubMed Costa MD, Henriques T, Munshi MN, Segal AR, Goldberger AL (2014) Dynamical glucometry: use of multiscale entropy analysis in diabetes. Chaos 24:033139CrossRefPubMed
15.
Zurück zum Zitat Costa M, Goldberger AL, Peng CK (2002) Multiscale analysis of complex physiologic time series. Phys Rev Lett 89:068102CrossRefPubMed Costa M, Goldberger AL, Peng CK (2002) Multiscale analysis of complex physiologic time series. Phys Rev Lett 89:068102CrossRefPubMed
16.
Zurück zum Zitat Humeau-Heurtier A (2015) The multiscale entropy algorithm and its variants: a review. Entropy 17:3110–3123CrossRef Humeau-Heurtier A (2015) The multiscale entropy algorithm and its variants: a review. Entropy 17:3110–3123CrossRef
17.
Zurück zum Zitat Augstein P, Vogt L, Kohnert KD, Heinke P, Salzsieder E (2010) Translation of personalized decision support into routine diabetes care. J Diabetes Sci Technol 4:1532–1539CrossRefPubMedPubMedCentral Augstein P, Vogt L, Kohnert KD, Heinke P, Salzsieder E (2010) Translation of personalized decision support into routine diabetes care. J Diabetes Sci Technol 4:1532–1539CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Metternich K (2008) Die Diabetes - Journal-Naehrwert - Tabelle: BE, KE und Kalorien auf einen Blick. Verlag Kirchheim + CoGmbH, Mainz Metternich K (2008) Die Diabetes - Journal-Naehrwert - Tabelle: BE, KE und Kalorien auf einen Blick. Verlag Kirchheim + CoGmbH, Mainz
20.
Zurück zum Zitat Rodbard D (2011) Glycemic variability: measurement and utility in clinical medicine and research—one viewpoint. Diabetes Technol Ther 11:1–4 Rodbard D (2011) Glycemic variability: measurement and utility in clinical medicine and research—one viewpoint. Diabetes Technol Ther 11:1–4
21.
Zurück zum Zitat Fritzsche G, Kohnert KD, Heinke P, Vogt L, Salzsieder E (2011) The use of a computer program to calculate the mean amplitude of glycemic excursions. Diabetes Technol Ther 13:319–325CrossRefPubMed Fritzsche G, Kohnert KD, Heinke P, Vogt L, Salzsieder E (2011) The use of a computer program to calculate the mean amplitude of glycemic excursions. Diabetes Technol Ther 13:319–325CrossRefPubMed
22.
Zurück zum Zitat Molnar GD, Taylor WF, Ho MM (1972) Day-to-day variation of continuously monitored glycemia: a further measure of diabetic instability. Diabetologia 8:342–348CrossRefPubMed Molnar GD, Taylor WF, Ho MM (1972) Day-to-day variation of continuously monitored glycemia: a further measure of diabetic instability. Diabetologia 8:342–348CrossRefPubMed
23.
Zurück zum Zitat McDonnel CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ (2005) A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 7:253–263CrossRef McDonnel CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ (2005) A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 7:253–263CrossRef
25.
Zurück zum Zitat Kohnert KD, Heinke P, Vogt L, Augstein P, Salzsieder E (2014) Declining β-cell function is associated with the lack of long-range negative correlation in glucose dynamics and increased glycemic variability: a retrospective analysis in patients with type 2 diabetes. J Clin Transl Endocrinol 1:192–199CrossRef Kohnert KD, Heinke P, Vogt L, Augstein P, Salzsieder E (2014) Declining β-cell function is associated with the lack of long-range negative correlation in glucose dynamics and increased glycemic variability: a retrospective analysis in patients with type 2 diabetes. J Clin Transl Endocrinol 1:192–199CrossRef
Metadaten
Titel
Associations of blood glucose dynamics with antihyperglycemic treatment and glycemic variability in type 1 and type 2 diabetes
verfasst von
K.-D. Kohnert
P. Heinke
L. Vogt
P. Augstein
A. Thomas
E. Salzsieder
Publikationsdatum
01.11.2017
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 11/2017
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-017-0682-2

Weitere Artikel der Ausgabe 11/2017

Journal of Endocrinological Investigation 11/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.